ReNeuron Group PLC | Mutual Funds
Mutual Funds that own ReNeuron Group PLC
CF Woodford Equity Income
6,141,257
19.41%
0
0.09%
07/31/2018
4,852,283
15.33%
40,891
0.47%
07/31/2018
Invesco Perpetual UK 2 Invt. Series - UK Strategic Income Fund
2,255,969
7.13%
-1
0.41%
03/29/2018
Invesco Perpetual UK Equity Pension Fund
764,149
2.42%
-1
0.21%
03/29/2018
Baillie Gifford UK & Balanced Fund - British Smaller Companies
256,442
0.81%
0
0.11%
04/30/2018
Old Mutual Woodford Equity Income Fund
244,672
0.77%
0
0.14%
07/31/2018
Hargreave Hale AIM VCT 1 Plc
131,832
0.42%
-974
0.15%
09/30/2017
Government Pension Fund - Global (The)
124,487
0.39%
-27,328
0%
12/31/2017
Hargreave Hale AIM VCT 2 Plc
92,070
0.28%
4,757
0.15%
02/28/2017
Aviva Investors - European Equity Fund
88,719
0.28%
0
0.05%
06/30/2018
| Address |
Pencoed Business Park
Pencoed BJ CF35 5HY
United Kingdom
|
|
Employees
|
- |
| Website |
http://reneuron.com |
| Updated |
07/08/2019 |
| ReNeuron Group Plc engages in the development of novel cell based therapies that target significant areas of unmet medical need. It develops its core stem cell assets such as CTX neural cell line and human retinal progenitor cells. The company was founded by John David Sinden in 1997 and is headquartered in Pencoed, the United Kingdom. |
